These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 2747138)

  • 1. [Critical evaluation of fructosamine as a control parameter in the assessment of diabetic metabolic regulation].
    Hay U; Sedlmayer A; Müller MM; Dorda W; Schernthaner G
    Klin Wochenschr; 1989 Apr; 67(7):379-85. PubMed ID: 2747138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of a change in posture on the diurnal variations of fructosamine concentration in diabetic patients].
    Willms B; Schumann E
    Wien Klin Wochenschr Suppl; 1990; 180():44-8; discussion 57-9. PubMed ID: 2321392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis of the diabetic metabolic status using fructosamine (and HbA1c) determination. The glycation quotient Glyc-Q, the glycation nomogram].
    Henrichs HR
    Wien Klin Wochenschr Suppl; 1990; 180():64-9; discussion 78-81. PubMed ID: 2321396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma protein glycation as measured by fructosamine assay.
    Mosca A; Carenini A; Zoppi F; Carpinelli A; Banfi G; Ceriotti F; Bonini P; Pozza G
    Clin Chem; 1987 Jul; 33(7):1141-6. PubMed ID: 3594841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fructosamine: an alternative assessment of past glycaemic control in developing countries.
    Islam N; Akhter J; Kayani N; Khan MA
    J Pak Med Assoc; 1993 Nov; 43(11):238-40. PubMed ID: 8114262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diurnal variations of fructosamine in patients with type II diabetes mellitus].
    Brunnbauer M; Küenburg E; Winter F; Müller MM; Prager R
    Wien Klin Wochenschr Suppl; 1990; 180():72-3; discussion 78-81. PubMed ID: 2321398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of plasma fructosamine in the assessment of diabetic control.
    Saeed BO; elWali NM; Atabani GS; Elmahdi EM; Mukhtar E
    Trop Geogr Med; 1991; 43(1-2):51-4. PubMed ID: 1750129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance and clinical significance of the new fructosamine assay in diabetic patients.
    Melzi d'Eril GV; Bosoni T; Solerte SB; Fioravanti M; Ferrari E
    Wien Klin Wochenschr Suppl; 1990; 180():60-3; discussion 78-81. PubMed ID: 2321395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Control of the metabolic state of diabetic patients by determining the concentration of serum glycosylated proteins (the fructosamine test)].
    Dogaru C; Deutsch G; Negrişanu G; Moldovan I; Băcanu G
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(5):449-58. PubMed ID: 2575276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of fasting blood glucose and serum fructosamine as a measure of diabetic control in non-insulin-dependent diabetes mellitus.
    Kruseman AC; Mercelina L; Degenaar CP
    Horm Metab Res Suppl; 1992; 26():59-62. PubMed ID: 1490693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fructosamine assay: an index of medium-term metabolic control parameters in diabetic disease.
    Lapolla A; Poli T; Barison A; Fedele D
    Diabetes Res Clin Pract; 1988 Feb; 4(3):231-5. PubMed ID: 3359924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [2,070 simultaneous determinations of blood glucose, glucosylated hemoglobin and fructosamine as index of metabolic control in 519 diabetic patients].
    Gómez Reyes D; Gea T; Rojas Hidalgo E
    Rev Clin Esp; 1989 Nov; 185(7):354-8. PubMed ID: 2623250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum fructosamine in patients with diabetes mellitus.
    Baker J; Reid I; Holdaway I
    N Z Med J; 1985 Jul; 98(782):532-5. PubMed ID: 3861965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of hyperlipoproteinemia on serum fructosamine].
    Drexel H; Patsch JR
    Wien Klin Wochenschr Suppl; 1990; 180():24-32; discussion 32-3. PubMed ID: 2321387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fluctuations in albumin on serum fructosamine assay.
    McCance DR; Coulter D; Smye M; Kennedy L
    Diabet Med; 1987; 4(5):434-6. PubMed ID: 2959433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of HbA1c, fructosamine and the main metabolic parameters in a non-insulin-dependent diabetic population].
    Magnati G; Arsenio L; Baroni MC; Bodria P; Bossi S; Delsignore R; Ippolito L; Mineo F; Strata A
    G Clin Med; 1990 Jan; 71(1):25-30. PubMed ID: 2365166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycated serum protein determination: comparison between thiobarbituric acid and fructosamine assays.
    Poli T; Lapolla A; Plebani M; Franchin A; Fedele D
    Acta Diabetol Lat; 1987; 24(3):241-7. PubMed ID: 3687316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of serum fructosamine in the metabolic control of children and adolescents with type I diabetes mellitus].
    Krause M; Pfüller H; Herbst D; Kruse K
    Monatsschr Kinderheilkd; 1987 Apr; 135(4):200-3. PubMed ID: 3600671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level of serum fructosamine in Saudi diabetic patients.
    Ajabnoor MA; Zawawi TH; Marzouki KM; Marzouki ZM
    Acta Diabetol Lat; 1990; 27(2):105-12. PubMed ID: 2378195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective determination of non-enzymatic glycosylated serum albumin as a medium term index of diabetic control.
    Wörner W; Pfleiderer S; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):218-22. PubMed ID: 8314651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.